Abstract
This chapter introduces a potential definitive treatment in the struggle against malignant brain tumors. In spite of successful steps in biomedical research, brain glioblastomas remain a death sentence in all cases. The difficulty in overcoming the blood–brain barrier (BBB) is the biggest obstacle for chemotherapeutics, which cannot reach the tumor bed as efficacious doses. The advent of nanotechnology could revolutionize the approach to that. Nanoparticles are versatile, thanks to their particular chemical configuration, and are able to go through the BBB carrying drugs or genes targeted against brain tumors. This will improve the efficacy of treatments and reduce also timing and costs of oncological patients.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
